Baicalin suppresses migration, invasion and metastasis of breast cancer via p38MAPK signaling pathway

Anti-Cancer Agents in Medicinal Chemistry

Volumn 13, Issue 6, 2013, Pages 923-931

  Wang, Xiu Feng ^a   Zhou, Qian Mei ^a   Du, Jia ^a   Zhang, Hui ^a   Lu, Yi Yu ^a   Su, Shi Bing ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Baicalin; Breast cancer; MDA MB 231 cell; Metastasis; Side effects

Indexed keywords

BAICALIN; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UROKINASE; UROKINASE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST METASTASIS; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR XENOGRAFT; WESTERN BLOTTING; WOUND HEALING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; DRUGS, CHINESE HERBAL; ENZYME INHIBITORS; FEMALE; FLAVONOIDS; HUMANS; LUNG; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SCUTELLARIA BAICALENSIS; SIGNAL TRANSDUCTION;

EID: 84880172411     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/18715206113139990143     Document Type: Article

References (36)

1. Parkin, D.M.; Fernandez, L.M. Use of statistics to assess the global burden of breast cancer. Breast J., 2006, 12(Suppl.1), S70-S80.
2. Ziegler, R.G.; Anderson, W.F.; Gail, M.H. Increasing breast cancer incidence in China: the numbers add up. J. Natl. Cancer Inst., 2008, 100 (19), 1339-1341.
3. Yang, L.; Li, L.D.; Chen, Y.D.; Parkin, D.M. Time trends, estimates and projects for breast cancer incidence and mortality in China. Chinese J. Oncol., 2006, 28(6), 438-440.
4. Wang, S.; Liu, Q.; Zhang, Y.; Liu, K.; Yu, P.F.; Liu, K.; Luan, J.L.; Duan, H.Y.; Lu, Z.Q.; Wang, F.F.; Wu, E.X.; Yagasaki, K.; Zhang, G.Y. Suppression of growth, migration and invasion of highlymetastatic human breast cancer cells by berbamine and its molecular mechanisms of action. Mol. Cancer, 2009, 8, 81.
5. Takahashi, H.; Chen, M.C.; Pham, H.; Anqst, E.; King, J.C.; Park, J.; Brovman, E.Y.; Ishiguro, H.; Harris, D.M.; Reber, H.A.; Hines, O.J.; Gukovskaya, A.S.; Go, V.L.; Eibl, G. Baicalein, a component of Scutellaria baicalensis, induces apoptosis by Mcl-1 downregulation in human pancreatic cancer cells. Biochim. Biophys. Acta., 2011, 1813(8), 1465-1474.
6. Gao, J.; Morgan, W.A.; Sanche-Medina, A.; Corcoran, O. The ethanol extract of Scutellaria baicalensis and the active compounds induce cell cycle arrest and apoptosis including up-regulation of p53 and Bax in human lung cancer cells. Toxicol. Appl. Pharmacol., 2011, 254(3), 221-228.
7. Du, G.; Han, G.; Zhang, S.; Lin, H.; Wu, X.; Wang, M.; Ji, L.; Lu, L.; Yu, L.; Liang, W. Baicalin suppresses lung carcinoma and lung metastasis by SOD mimic and HIF-1alpha inhibition. Eur. J. Pharmacol., 2010, 630(1-3), 121-130.
8. Wang, N.; Tang, L.J.; Zhu, G.Q.; Peng, D.Y.; Wang, L.; Sun, F.N.; Li, Q.L. Apoptosis induced by baicalin involving up-regulation of P53 and bax in MCF-7 cells. J. Asian Nat. Prod. Res., 2008, 10(11-12), 1129-1135.
9. Wang, C.Z.; Li, X.L.; Wang, Q.F.; Mehendale, S.R.; Yuan, C.S. Selective fraction of Scutellaria baicalensis and its chemopreventive effects n MCF-7 human breast cancer cells. Phytomedicine, 2010, 17(1), 63-68.
10. Gu, Z.Q.; Sun, Y.H.; Xu, C.L.; Liu, Y. Study of baicalin in inducing prostate cancer cell line DU145 apoptosis in vitro. Zhongguo Zhong Yao Za Zhi. 2005, 30(1), 63-66.
11. Motoo, Y.; Sawabu, N. Antitumor effects of saikosaponins, baicalin and baicalein on human hepatoma cell lines. Cancer Lett., 1994, 86, 91-95.
12. Kato, M.; Liu, W.; Yi, H.; Asai, N.; Hayakawa, A.; Kozaki, K.; Takahashi, M.; Nakashima, I. The herbal medicine Sho-saiko-to inhibits growth and metastasis of malignant melanoma primarily developed in ret-transgenic mice. J. Invest. Dermatol., 1998, 111(4), 640-644.
13. Zhou, Q.M.; Wang, S.; Zhang, H.; Lu, Y.Y.; Wang, X.F.; Motoo, Y.; Su, S.B. The combination of baicalin and baicalein enhances apoptosis via the ERK/p38MAPK pathway in human breast cancer cells. Acta Pharmacol. Sin., 2009, 30(12), 1648-1658.
14. Bogenrieder, T.; Herlyn, M. Axis of evil: molecular mechanisms of cancer metastasis. Oncogene., 2003, 22, 6524-6536.
15. Liu, L.; Liu, L.J.; Zhao, P. Expressions and clinicopathological significance of matrix metalloproteinase-2, metalloproteinase-9 and E-cadherin in breast cancer tissues. China J. Mod. Med., 2008, 18(21), 3149-3151.
16. Liu, J.; Zhang, X.M. Expression of urokinase-type plasminogen activator (uPA) and uPA receptor (uPAR) in breast cancer and its significance. J. Oncol., 2005, 11(3), 202-204.
17. Martin, Köbel.; Gudrun, Pohl.; Wolfgang, D.; Schmitt, Steffen Hauptmann, Tian-Li Wang, Ie-Ming Shih. Activation of mitogen activated protein kinase is required for migration and invasion of placental site trophoblastic tumor. Am. J. Pathol., 2005, 167(3), 879-885.
18. Reddy, K.B.; Nabha, S.M.; Atanaskova, N. Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev., 2003, 22(4), 395-403.
19. Han, Y.C.; Zeng, X.X.; Wang, R.; Zhao, Y.; Li, B.L.; Song, M. Correlation of p38 mitogen-activated protein kinase signal transduction pathway to uPA expression in breast cancer. Chinese J. Cancer, 2007, 26(1), 48-53.
20. Han, Y.C.; Liu, L.Y.; Yang, D.X.; Wang, G.H. Increase of p-p38 and uPA expression in human breast cancer. Basic. Clin. Med., 2009, 29(2), 170-173.
21. Duffy, M.J.; McGowan, P.M.; Gallagher, W.M. Cancer invasion and metastasis: changing views. J. Pathol., 2008, 214(3), 283-293.
22. Du, G.; Han, G.; Zhang, S.; Lin, H.; Wu, X.; Wang, M.; Ji, L.; Lu, L.; Yu, L.; Liang, W. Baicalin suppresses lung carcinoma and lung metastasis by SOD mimic and HIF-1β inhibition. Eur. J. Pharmacol., 2010, 630(1-3), 121-130.
23. Price, J.T.; Thompson, E.W. Mechanisms of tumor invasion and metastasis: emerging targets for therapy. Expert Opin. Ther. Targets. 2002, 6, 217-233.
24. Stamenkovic, I. Extracellular matrix remodeling: the role of matrix metalloproteinases. J. Pathol., 2003, 200, 448-464.
25. Sidenius, N.; Blasi, F. The urokinase plasminogen activator system in cancer: recent advance and implication for prognosis and therapy. Cancer Memsmsis. Rev., 2003, 22(2-3), 205-222.
26. Huang, X.X.; Xu, D.P.;Wang, L.Q.; Gao, L.Y. Expression of MMP-2 and MMP-9 in the tissues of breast carcinoma and its relationship with tumor invasion and metastasis. Chinese J. Clin. Rehabil., 2004, 8(11):2190-2192.
27. La Rocca, G.; Pucci-Minafra, I.; Marrazzo, A. Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera. Br. J. Cancer. 2004, 90(7), 1414-1421.
28. Giannopoulou, I.; Mylona, E.; Kapranou, A. The prognostic value of the topographic distribution of uPAR expression in invasive breast carcinomas. Cancer Lett., 2007, 246(1-2), 262-267.
29. Van Waes, C. Nuclear factor-kappaB in development, prevention, and therapy of cancer. Clin. Cancer Res., 2007, 13(4), 1076-1082.
30. Karin, M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006, 441(7092), 431-436.
31. Yao, Q.; Luo, J.R.; Chen, J.H.; Zhang, J.L.; Yuan, S.F.; Ling, R.; Wang, L. Expression and activation of MAPK pathway signaling molecules in human breast cancer cell lines. Chin. J. Cell. Mol. Immunol., 2004, 20(3), 328-330.
32. Hong, I.K.; Kim, Y.M.; Jeoung, D.I.; Kim, K.C.; Lee, H. Tetraspanin CD9 induces MMP-2 expression by activating p38 MAPK, JNK and c-Jun pathways in human melanoma cells. Exp. Mol. Med., 2005, 37(3), 230-239.
33. Yu, J.; Bian, D.; Mahanivong, C.; Cheng, R.K.; Zhou, W.; Huang, S. p38 Mitogen-activated protein kinase regulation of endothelial cell migration depends on urokinase plasminogen activator expression. J. Biol. Chem., 2004, 279(48), 50446-50454.
34. Mohammad, M.A.; Zeeneldin, A.A.; Abd Elmageed, Z.Y.; Khalil, E.H.; Mahdy, S.M.; Sharada, H.M.; Sharawy, S.K.; Abdel-Wahab, A.H. Clinical relevance of cyclooxygenase-2 and matrix metalloproteinases (MMP-2 and MT1-MMP) in human breast cancer tissue. Mol. Cell Biochem., 2012, 366, 269-275.
35. Jones, J.L.; Glynn, P.; Walker, R.A. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. J. Pathol., 1999, 189, 161-168.
36. Figueira, R.C.; Gomes, L.R.; Neto, J.S.; Silva, F.C.; Silva, I.D.; Sogayar, M.C. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential. BMC Cancer, 2009, 9, 20.